Respain: Dosing, Side Effect & Interaction

Indications/Uses

Management of mild to moderate acute pain; OA.

Dosage/Direction for Use

Acute pain & OA 1 cap 3 times daily.

Contraindications

Hypersensitivity (eg, anaphylactic & serious skin reactions). History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. CABG surgery. Active gastric or intestinal ulcer, bleeding or perforation. 3rd trimester pregnancy.

Special Precautions

Reduced doses in patients w/ hepatic disease; initiate at the lowest dose & discontinue if ineffective.

Adverse Reactions

CV thrombotic events, GI bleeding, ulceration & perforation, hepatotoxicity, HTN, heart failure & edema, renal toxicity & hyperkalemia, anaphylactic reactions, serious skin reactions, hematologic toxicity.

View ADR Reporting Link

MIMS Class

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

ATC Classification

M01AB05 - diclofenac ; Belongs to the class of acetic acid derivatives and related substances of non-steroidal antiinflammatory and antirheumatic products.

Regulatory Classification

K

Presentation/Packing

Form

Respain cap 35 mg

Packing/Price

3 × 10's

Respain

diclofenac

Manufacturer:

Fahrenheit